These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11347331)

  • 1. Clinico-laboratory study of methylprednisolone and cyclophosphamide treatment in patients with multiple sclerosis relapse.
    Manova MG; Kostadinova II; Rangelov AA
    Folia Med (Plovdiv); 2000; 42(3):20-5. PubMed ID: 11347331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitoxantrone: a review of its use in multiple sclerosis.
    Scott LJ; Figgitt DP
    CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The comparison of the effectiveness of treatment of multiple sclerosis relapse with high doses of methylprednisolone, alpha-24 corticotropin and cyclophosphamide].
    Paradowski B; Gruszka E; Pokryszko A
    Pol Merkur Lekarski; 1999 Jun; 6(36):305-7. PubMed ID: 10481540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of progressive multiple sclerosis with pulse cyclophosphamide/methylprednisolone: response to therapy is linked to the duration of progressive disease.
    Hohol MJ; Olek MJ; Orav EJ; Stazzone L; Hafler DA; Khoury SJ; Dawson DM; Weiner HL
    Mult Scler; 1999 Dec; 5(6):403-9. PubMed ID: 10618696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of progressive multiple sclerosis with monthly pulsed cyclophosphamide-methylprednisolone: predictive factors of treatment response].
    Delmont E; Chanalet S; Bourg V; Soriani MH; Chatel M; Lebrun C
    Rev Neurol (Paris); 2004 Jul; 160(6-7):659-65. PubMed ID: 15247854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis.
    Brochet B; Deloire MS; Perez P; Loock T; Baschet L; Debouverie M; Pittion S; Ouallet JC; Clavelou P; de Sèze J; Collongues N; Vermersch P; Zéphir H; Castelnovo G; Labauge P; Lebrun C; Cohen M; Ruet A;
    PLoS One; 2017; 12(1):e0168834. PubMed ID: 28045953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.
    Grootscholten C; Ligtenberg G; Hagen EC; van den Wall Bake AW; de Glas-Vos JW; Bijl M; Assmann KJ; Bruijn JA; Weening JJ; van Houwelingen HC; Derksen RH; Berden JH;
    Kidney Int; 2006 Aug; 70(4):732-42. PubMed ID: 16820790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Methylprednisolone and cyclophosphamide pulse therapy of severe systemic lupus erythematosus in children].
    Hu J; Li CW; Zhang X; Pi SH; Zhao JS; Chen XY; Liu Y
    Zhonghua Er Ke Za Zhi; 2003 Jun; 41(6):430-4. PubMed ID: 14748998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Favorable response to intravenous methylprednisolone and cyclophosphamide in children with severe neuropsychiatric lupus.
    Baca V; Lavalle C; García R; Catalán T; Sauceda JM; Sánchez G; Martínez I; Ramírez ML; Márquez LM; Rojas JC
    J Rheumatol; 1999 Feb; 26(2):432-9. PubMed ID: 9972981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wegener's granulomatosis: clinical and laboratory results of a university hospital study of 20 patients from Turkey.
    Ozbalkan Z; Kiraz S; Ozturk MA; Ertenli AI; Apras S; Calguneri M
    Clin Rheumatol; 2006 May; 25(3):358-63. PubMed ID: 16362442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunosuppressive treatment in multiple sclerosis].
    Oliveira TV; Gorz-Reinhardt AM; Gracia CM; Bittencourt PR
    Arq Neuropsiquiatr; 1992 Sep; 50(3):295-301. PubMed ID: 1308406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of worsening multiple sclerosis with mitoxantrone: a review.
    Fox EJ
    Clin Ther; 2006 Apr; 28(4):461-74. PubMed ID: 16750460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous cyclophosphamide combined with methylprednisolone in the treatment of severe refractory rheumatoid arthritis: the effect on lymphocytes.
    Lacki JK; Leszczynski P; Mackiewicz SH
    J Investig Allergol Clin Immunol; 1996; 6(4):232-6. PubMed ID: 8844499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinico-electrophysiological correlates in patients with relapsing-remitting multiple sclerosis.
    Manova MG; Kostadinova II; Chalakova-Atanasova NT; Temenlieva VK; Petrova NS
    Folia Med (Plovdiv); 2001; 43(3):5-9. PubMed ID: 11930834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary analysis of a trial of pulse cyclophosphamide in IFN-beta-resistant active MS.
    Smith D
    J Neurol Sci; 2004 Aug; 223(1):73-9. PubMed ID: 15261565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus.
    Saha M; Powell AM; Bhogal B; Black MM; Groves RW
    Br J Dermatol; 2010 Apr; 162(4):790-7. PubMed ID: 19922532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic potential of interferon beta-1b and related drugs in multiple sclerosis: comparative meta-analysis].
    Cendrowski W
    Neurol Neurochir Pol; 2001; 35(4 Suppl):125-38. PubMed ID: 11873611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regression of Henoch-Schönlein disease with intensive immunosuppressive treatment.
    Faedda R; Pirisi M; Satta A; Bosincu L; Bartoli E
    Clin Pharmacol Ther; 1996 Nov; 60(5):576-81. PubMed ID: 8941031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up study of MS patients treated with high-dose intravenous methylprednisolone.
    Frequin ST; Lamers KJ; Barkhof F; Borm GF; Hommes OR
    Acta Neurol Scand; 1994 Aug; 90(2):105-10. PubMed ID: 7801735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
    Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
    Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.